SCHEMBL4850237

SCHEMBL4850237

COc1cc(Cl)ccc1-c1nnco1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 6/20 0.65
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.53
MAPK1 P28482 1/20 0.53
MAPT P10636 3/20 0.50
KMT2A Q03164 4/20 0.48
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
HSD17B10 Q99714 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
F11 P03951 1/20 0.41
KLKB1 P03952 1/20 0.41
GUSB P08236 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2448308 0.88 NOTUM (0.60) NOTUMALDH1A1HPGDMAPK1MAPT
SCHEMBL15742918 0.81 IMPDH2 (0.56) NOTUMALDH1A1HPGDMAPK1MAPT
SCHEMBL1106992 0.79 NOTUM (0.51) NOTUMALDH1A1MAPTKMT2AGAA
SCHEMBL23451556 0.79 NOTUM (1.00) NOTUMALDH1A1MAPK1MAPTKMT2A
SCHEMBL30412729 0.79 NOTUM (1.00) NOTUMALDH1A1MAPK1MAPTKMT2A
SCHEMBL27457889 0.78 NOTUM (0.70) NOTUMALDH1A1HPGDMAPK1KMT2A
SCHEMBL6769153 0.77 NOTUM (0.68) NOTUMALDH1A1MAPTKMT2AGAA
SCHEMBL27493203 0.77 KMT2A (0.57) NOTUMALDH1A1HPGDMAPK1MAPT
SCHEMBL24985944 0.77 CA12 (0.51) NOTUMALDH1A1HPGDMAPK1MAPT
SCHEMBL20360238 0.76 NOTUM (0.66) NOTUMHPGDMAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456169-B2 Heterocyclic kinase inhibitors ABBOTT LABORATORIES INC. (US) 2008-11-25 US disclosed
US-20070254867-A1 Heterocyclic Kinase Inhibitors ABBVIE INC. 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254867-A1 Heterocyclic Kinase Inhibitors MAP3K20, MAP3K19, MAP4K2 NOTUM 2490/4885ALDH1A1 3257/4885HPGD 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.